top

Licensing out status

Code
2010 Turkey+Middle East/
DEM Pharmaceuticals
Long-acting interferon-alpha SC
(HCV & Behcet's Disease
HL143
2010 Singapore+Malaysia+Brunei/
YSP
ADC liposomal gel
(Atopic dermatitis)
HL009
2010 Indonesia/Bernofarm XC Hybrid Combination HL007

Currentlly 20 global cooperations.
Various types of cooperations for worldwide market

Code
2007 France / Nautilus Biotech Oral Protein tderapentics Engineered INF-α, INF-β,
hGH, EPO
2006 Sandoz Generics Sandoz Generics Ramipril, Carvedilol, Atorvastatin
2006 Minophagen Liver disease Glycyrrhizin Inj.
2005 Germany / Helm Ani-coagulant Clopidogrel besylate
2005 Italy / Alfa Wassermann GI Antibiotics Rifaximin (Normix)
2004 Switzerland / Drossapharm Hemorrhoid, Varicose vein Naftazone
2004 Belgium / SMB Extended release analgesic Tramadol
2003 Japan / TOA Probiotics 3 Strains
2003 USA / Atrix(QLT) Prostate Cancer Leuprolide (Eligard)
2003 Germany / Bayer Anti-hypertensive agent Baypress (Nitrendipine)
2002 USA / Baxter Nutritional solution Clinomel, Oliclinomel C-met
2001 Japan / SSP, Hisamitsu Goblet cell suppressor Fudostein / Expectorant
2001 China / Lanzhou
Biological Product Institute
Botulinum toxin Inj. BTXA
1999 Japan / Hayashibara Hepatitis B, C Kidney cancer, Leukemia Natural Interferon-alpha-2b+7+8
1996 Japan / Mitsubishi Arthritis Joint injection (Lipo-steroid)
1992 Japan / Toyama Antibiotics Cefbuperazone Inj.
Pazufloxacin Inj.
1998 GSK Anti-dermatitis agent Bactroban oint.
1988 Merck Antibiotics Reposforen Inj.
1985 Italy / Rotta NSAIDs Proglumethacin
1984 Japan / Ajinomoto Nutrutuonal Solution PN-Twin
1980 Italy / Zambon Antibiotics Thiamphenicol